NC
WHWK

Nexthera Capital’s Whitehawk Therapeutics WHWK Stock Holding History

Nexthera Capital’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19,925
Closed -$1.24M – 68
2018
Q2 		$1.24M Buy
+19,925
New +$1.2M 0.19% 37

Other funds holding WHWK

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Nexthera Capital's WHWK Position: Q3 2018 in Review

Nexthera Capital sold out of Whitehawk Therapeutics (WHWK) in Q3 2018, closing a stake of 19,925 shares — an estimated $1.24M sold.

Nexthera Capital first reported a position in WHWK in Q2 2018 and held it in 1 quarter. The position peaked at $1.24M in Q2 2018. 20 funds tracked by Wall St. Rank hold WHWK as of Q3 2018.

  • Nexthera Capital reported no remaining Whitehawk Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Nexthera Capital sold 19,925 Whitehawk Therapeutics shares in Q3 2018, an estimated $1.24M.
  • Nexthera Capital first reported a position in Whitehawk Therapeutics in Q2 2018 and held it in 1 quarter.
  • Nexthera Capital's Whitehawk Therapeutics position peaked at $1.24M in Q2 2018.
  • 20 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2018.

Based on Nexthera Capital's 13F filing for Q3 2018, filed 14 Nov 2018.